Prelude Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Prelude Capital Management’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8,500	Closed	-$231K	–	1754
2015 Q4	$231K	Buy	+8,500	New	+$219K	0.04%	495

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Prelude Capital Management's MR Position: Q1 2016 in Review

Prelude Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 8,500 shares — an estimated $231K sold.

Prelude Capital Management first reported a position in MR in Q4 2015 and held it in 1 quarter. The position peaked at $231K in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Prelude Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Prelude Capital Management sold 8,500 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $231K.
Prelude Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2015 and held it in 1 quarter.
Prelude Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $231K in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Prelude Capital Management's 13F filing for Q1 2016, filed 16 May 2016.